#  Skylark Bio investigating new gene therapy trial for deafness 

 





Skylark is among several biotechs investigating different genetic mutations for future therapies.



 

August 11, 2026

 

 

[Watch WGBH segment](https://www.wgbh.org/podcasts/the-curiosity-desk/whats-the-rocky-horror-drama) | [Read STAT News article | ](https://www.statnews.com/2026/08/11/skylark-bio-gjb2-otoferlin-gene-therapies-for-deafness/?utm_source=OCERMarketingCloud&utm_medium=email&utm_campaign=HMS+in+the+News+(August+11%2c+2026)&utm_content=https%3a%2f%2fwww.statnews.com%2f2026%2f08%2f11%2fskylark-bio-gjb2-otoferlin-gene-therapies-for-deafness%2f)[Read New York Times article](https://www.nytimes.com/2026/07/21/health/gene-therapy-rare-diseases-epilepsy.html) | [Read Broad Center Press Release](https://www.broadinstitute.org/news/broad-institute-boston-childrens-hospital-and-jackson-laboratory-launch-center-therapeutic)



 

 

 



 

 

 Share on:- [     Facebook ](#)
- [     Twitter ](#)
- [     Linkedin ](#)